Ideal Image Offers CoolTone™ by CoolSculpting® Nationwide

September 11, 2020

Ideal Image: After successful clinical trials, America’s #1 MedSpa, proudly announces all 150+ locations will offer the FDA-approved service CoolTone™ by Coolsculpting® which leverages Magnetic Muscle Stimulation (MMS technology) to strengthen the abdomen, thighs and buttocks. The service will launch in phases through September 2020.

Ideal Image reports with an in-office, 30-minute treatment, CoolTone™ provides results after one session, equivalent to 20,000 sit-ups. Four treatments spaced over two consecutive weeks guarantees best results: a flatter stomach and toned muscles. Note results vary based on the individual’s goals. Ideal Image recommends patients engage in Coolsculpting® as a foundational treatment prior to CoolTone™ for an even better muscle-toning, fat-eliminating experience.

Ideal Image is also offering CoolTone™ at up to a 50% discount through September. Given all treatments are customized per patient, interested consumers can schedule a free virtual consultation to plan their treatment and determine exact pricing here.

As a result of COVID-19, Ideal Image CEO David Prokupek quickly pivoted the business to accommodate virtual appointments while also staying abreast of new treatments. “At Ideal Image we believe confidence is key to being your best self. To this end, we equip our patients with non-invasive aesthetic services to offer real people real results. By adding CoolTone™ to our service menu, we further our position as America’s #1 MedSpa, providing treatments which are accessibility, affordable and safe,” says Prokupek.

In addition to outlining safety protocols for patients, Ideal Image is taking the following steps to ensure safety during this time:

  • Virtual consultations are available for all patients. All treatments are done safely in one of Ideal Image’s 150+ clinics.
  • Ideal Image medical professionals undergo a health screening, along with temperature checks prior to starting their shifts.
  • Every medical professional follows a strict and thorough hand-washing procedure and clinic disinfectant schedule, effective against the Human Coronavirus, HIV, HBV, HCV, HSV, SARS and H1N1 as well as others.
  • Masks are worn by all medical experts for the entirety of their shift.

Additionally, medical professionals and technicians interested in a career with Ideal Image can apply here to request information about Ideal Image’s state-of-the-art Cosmetic Institute, where licensed medical and nursing professionals receive rigorous training in the most up-to-date and effective protocols.

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”